LifeMD, Inc. to Participate in Upcoming Investor Conferences
November 18, 2022 16:05 ET
|
LifeMD, Inc.
NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the following...
LifeMD, Inc. Reports Third Quarter 2022 Results
November 10, 2022 16:05 ET
|
LifeMD, Inc.
Fourteenth consecutive quarter of record consolidated revenue. Third quarter 2022 consolidated revenue of $31.4 million up 26% from the same year ago period.Adjusted EPS of $(0.03), 91% improvement...
LifeMD, Inc. to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 10, 2022
October 26, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the...
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
September 27, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash...
LifeMD Appoints Bobby Jindal to the Board of Directors
September 20, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Sept. 20, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, is pleased to announce its appointment of Bobby Jindal, the 55th Governor of...
LifeMD Expands Primary Care Platform’s Diagnostic Capabilities with New At-Home Screening Kits For Early Warning Signs Of Cancer
September 14, 2022 08:00 ET
|
LifeMD, Inc.
Patients can now access At-home kits for early warning signs of colon cancer and breast cancer through LifeMD’s primary care platform. LifeMD to provide free Breast and Colon screening kits with...
LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis
August 22, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that its wholly-owned allergy telehealth subsidiary,...
LifeMD, Inc. Reports Second Quarter 2022 Results
August 11, 2022 16:05 ET
|
LifeMD, Inc.
Record second quarter 2022 consolidated revenue of $30.5 million up 37% from the same year ago period.Adjusted EPS of $(0.22), 52% improvement versus the prior year, 12% sequentially.Remain on track...
LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022
July 27, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the...
LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions
July 19, 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD, a leading direct-to-patient telehealth company, today announced the continued and rapid expansion of its Virtual Primary Care...